A Phase II Study of Epothilone B Analog (BMS-247550) [ixabepilone] in Advanced Soft Tissue Sarcomas
Phase of Trial: Phase II
Latest Information Update: 22 Apr 2015
At a glance
- Drugs Ixabepilone (Primary)
- Indications Leiomyosarcoma; Sarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- 15 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 29 Sep 2005 New trial record.